BG64166B1 - Твърди дозирани форми, съдържащи флурбипрофен - Google Patents

Твърди дозирани форми, съдържащи флурбипрофен Download PDF

Info

Publication number
BG64166B1
BG64166B1 BG102526A BG10252698A BG64166B1 BG 64166 B1 BG64166 B1 BG 64166B1 BG 102526 A BG102526 A BG 102526A BG 10252698 A BG10252698 A BG 10252698A BG 64166 B1 BG64166 B1 BG 64166B1
Authority
BG
Bulgaria
Prior art keywords
flurbiprofen
dosage form
sugar
solid
patient
Prior art date
Application number
BG102526A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG102526A (en
Inventor
David M. Barrett
Carl S. Smith
David M. Thurgood
Original Assignee
The Boots Company P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Boots Company P.L.C. filed Critical The Boots Company P.L.C.
Publication of BG102526A publication Critical patent/BG102526A/xx
Publication of BG64166B1 publication Critical patent/BG64166B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
BG102526A 1995-11-22 1998-06-09 Твърди дозирани форми, съдържащи флурбипрофен BG64166B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9523833.3A GB9523833D0 (en) 1995-11-22 1995-11-22 Medical treatment
PCT/EP1996/005208 WO1997018802A1 (en) 1995-11-22 1996-11-21 Pharmaceutical compositions comprising flurbiprofen

Publications (2)

Publication Number Publication Date
BG102526A BG102526A (en) 1999-02-26
BG64166B1 true BG64166B1 (bg) 2004-03-31

Family

ID=10784245

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102526A BG64166B1 (bg) 1995-11-22 1998-06-09 Твърди дозирани форми, съдържащи флурбипрофен

Country Status (21)

Country Link
US (2) US5889057A (uk)
EP (1) EP0862424B1 (uk)
CN (1) CN1148177C (uk)
AT (1) ATE252382T1 (uk)
AU (1) AU707749B2 (uk)
BG (1) BG64166B1 (uk)
CA (1) CA2238271C (uk)
CZ (1) CZ289643B6 (uk)
DE (1) DE69630460T2 (uk)
DK (1) DK0862424T3 (uk)
ES (1) ES2208768T3 (uk)
GB (1) GB9523833D0 (uk)
HU (1) HU225235B1 (uk)
IL (1) IL124568A0 (uk)
NO (1) NO317287B1 (uk)
NZ (1) NZ322933A (uk)
PT (1) PT862424E (uk)
RU (1) RU2203655C2 (uk)
SK (1) SK284092B6 (uk)
UA (1) UA46807C2 (uk)
WO (1) WO1997018802A1 (uk)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
AU8107998A (en) * 1997-05-22 1998-12-11 Boots Company Plc, The Pharmaceutical compositions
GB9710521D0 (en) * 1997-05-22 1997-07-16 Boots Co Plc Process
WO1998052545A1 (en) * 1997-05-22 1998-11-26 The Boots Company Plc Pharmaceutical compositions of flurbiprofen and burn-masking agent for treating sore throat
EP1206283A2 (en) * 1999-05-17 2002-05-22 Aesgen, Inc. Improved cellular uptake of bioactive agents
AU2001257022B2 (en) * 2000-04-13 2005-02-03 Mayo Foundation For Medical Education And Research Abeta 42 lowering agents
EP1446118B1 (en) * 2001-11-13 2008-01-09 Pharmacia Corporation Oral dosage form of parecoxib
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
WO2004012662A2 (en) * 2002-08-01 2004-02-12 Aesgen, Inc. Improved treatment of cancer with glutamine
WO2004071431A2 (en) * 2003-02-05 2004-08-26 Myriad Genetics, Inc. Method and composition for treating neurodegenerative disorders
US20040265359A1 (en) * 2003-04-17 2004-12-30 Sacks Gordon S. Oral delivery formulations of L-glutamine
JP2007528857A (ja) * 2003-07-11 2007-10-18 ミリアド ジェネティクス， インコーポレイテッド アルツハイマー病の処置のための薬学的方法、投与レジメンおよび投薬形態
FR2865648B1 (fr) * 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
WO2006001877A2 (en) * 2004-04-13 2006-01-05 Myriad Genetics, Inc. Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
KR20070004036A (ko) * 2004-04-29 2007-01-05 키스톤 리테이닝 월 시스템스, 아이엔씨 벽, 옹벽 및 그 외 유사한 것을 위한 베니어
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
BRPI0514303A (pt) * 2004-08-11 2008-06-10 Myriad Genetics Inc composição farmacêutica e método para tratar distúrbios neurodegenerativos
GB2423710A (en) * 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
EP1909777A2 (en) * 2005-07-22 2008-04-16 Myriad Genetics, Inc. High drug load formulations and dosage forms
AU2006312119B2 (en) * 2005-11-02 2010-04-29 Teikoku Pharma Usa, Inc. Organoleptically acceptable ibuprofen oral dosage formulations, methods of making and using the same
US7282224B1 (en) * 2006-06-09 2007-10-16 Guthy-Renker Corporation Pain relief composition
WO2008006099A2 (en) * 2006-07-07 2008-01-10 Myriad Genetics, Inc. Treatment of psychiatric disorders
US7754234B2 (en) * 2006-07-12 2010-07-13 Jones Thomas L Composition and method of treating a sore throat
US20080107747A1 (en) * 2006-10-23 2008-05-08 Roederer Joy E Pain relief composition
EA200901188A1 (ru) * 2007-07-23 2010-04-30 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Органолептически приемлемые дозированные лекарственные формы индольных агонистов серотониновых рецепторов для перорального применения и способы их применения
HUE052685T2 (hu) 2009-05-19 2021-05-28 Neuroderm Ltd Dopa-dekarboxiláz inhibitorok folyamatos adagolására szolgáló készítmények
IT1397132B1 (it) 2009-12-01 2013-01-04 Alfa Wassermann Spa Composizioni comprendenti antiinfiammatori non steroidei.
RS57047B1 (sr) * 2010-11-15 2018-05-31 Neuroderm Ltd Neprekidno davanje l dope, inhibitora dopa dekarboksilaze, inhibitora katehol-o-metil transferaze i kompozicije za iste
GB201021267D0 (en) * 2010-12-15 2011-01-26 Reckitt Benckiser Healthcare Int Ltd Novel pharmaceutical formulation
NZ703341A (en) 2012-06-05 2016-11-25 Neuroderm Ltd Compositions comprising apomorphine and organic acids and uses thereof
GB201216893D0 (en) 2012-09-21 2012-11-07 Aesica Pharmaceuticals Ltd Drug substance preparations, pharmaceutical compositions and dosage forms comprising s-(+)-flurbiprofen
ES2836325T3 (es) 2014-03-13 2021-06-24 Neuroderm Ltd Composiciones del inhibidor de la dopa descarboxilasa
US10258585B2 (en) 2014-03-13 2019-04-16 Neuroderm, Ltd. DOPA decarboxylase inhibitor compositions
CN110812331A (zh) * 2018-08-10 2020-02-21 北京普德康利医药科技发展有限公司 一种氟比洛芬咽部滞留颗粒
US11844754B2 (en) 2020-11-17 2023-12-19 Neuroderm, Ltd. Methods for treatment of Parkinson's disease
US11331293B1 (en) 2020-11-17 2022-05-17 Neuroderm, Ltd. Method for treatment of Parkinson's disease
US11213502B1 (en) 2020-11-17 2022-01-04 Neuroderm, Ltd. Method for treatment of parkinson's disease
CN118125916A (zh) * 2022-09-23 2024-06-04 南京知和医药科技有限公司 一种s-（+）-氟比洛芬盐及其制备方法、药物组合物和用途

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1062721A (en) * 1975-12-15 1979-09-18 Anthony A. Sinkula Propionic acid derivatives
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
JPH0647532B2 (ja) * 1983-08-31 1994-06-22 ジ アツプジヨン カンパニ− 歯槽骨吸収の治療
AU6656886A (en) * 1985-12-16 1987-06-18 Cilag A.G. Pharmaceutical composition of suprofen
AU8320387A (en) * 1986-10-22 1988-05-25 Upjohn Company, The Treatment of gingivitis with ibuprofen or flurbiprofen
JPS63156715A (ja) * 1986-12-19 1988-06-29 Teisan Seiyaku Kk 即効性の徐放化製剤
JP2540581B2 (ja) * 1988-02-04 1996-10-02 三省製薬株式会社 外用剤
US4931473A (en) * 1989-02-15 1990-06-05 Richardson-Vicks Inc. Anesthetic oral compositions
US5190981A (en) * 1989-08-17 1993-03-02 Sepracor Inc. Formulation containing S(+) enantiomer of flurbiprofen or ketoprofen and method of use for oral administration for prevention and treatment of bone loss associated with periodontal disease
DK0486561T4 (da) * 1989-08-17 1999-04-26 Sepracor Inc Bukkalt præparat indeholdende S(+)-ketoprofen
JP2738092B2 (ja) * 1989-11-17 1998-04-08 ライオン株式会社 口腔用組成物
JPH0426618A (ja) * 1990-05-21 1992-01-29 Japan Tobacco Inc トローチ剤
IT1243342B (it) * 1990-07-13 1994-06-10 Farcon Ag Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria
DE4028906A1 (de) * 1990-09-12 1992-03-19 Paz Arzneimittelentwicklung Arzneimittel sowie deren herstellung und deren verwendung bei der bekaempfung von schmerzen und/oder entzuendungen und/oder fieber an tieren und menschen
DE69230151T2 (de) * 1992-12-04 2000-03-09 Mayor Pharmaceuticals Laboratories, Inc. Sprühfähige analgetische zusammensetzung und verfahren zu irher verwendung
EP0674527A1 (en) * 1992-12-21 1995-10-04 The Procter & Gamble Company Use of s(+) antipodes of analgesic agents for the manufacture of a composition to treat respiratory disorders
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
ES2211916T3 (es) * 1994-09-02 2004-07-16 Virginia Commonwealth University Composicion para aliviar dolor, que contiene un analgesico no narcortico y un potenciador de analgesia.
US5567733B1 (en) * 1995-04-27 1999-08-24 Jon G Dishler Irritation relief using nonsteroidal anti-inflammatory compounds
JPH11508593A (ja) * 1995-07-05 1999-07-27 ザ、プロクター、エンド、ギャンブル、カンパニー 加温化合物
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
ATE288255T1 (de) * 1996-04-12 2005-02-15 Novadel Pharma Inc Polares bukkales spray
US5955098A (en) * 1996-04-12 1999-09-21 Flemington Pharmaceutical Corp. Buccal non polar spray or capsule

Also Published As

Publication number Publication date
CN1148177C (zh) 2004-05-05
PT862424E (pt) 2004-02-27
CN1207677A (zh) 1999-02-10
AU2611997A (en) 1997-06-11
ATE252382T1 (de) 2003-11-15
AU707749B2 (en) 1999-07-22
EP0862424B1 (en) 2003-10-22
GB9523833D0 (en) 1996-01-24
US5889057A (en) 1999-03-30
EP0862424A1 (en) 1998-09-09
IL124568A0 (en) 1998-12-06
ES2208768T3 (es) 2004-06-16
NO982294L (no) 1998-07-20
DE69630460T2 (de) 2004-08-19
RU2203655C2 (ru) 2003-05-10
WO1997018802A1 (en) 1997-05-29
HUP0000180A2 (hu) 2000-08-28
SK66598A3 (en) 1998-12-02
UA46807C2 (uk) 2002-06-17
CA2238271A1 (en) 1997-05-29
NZ322933A (en) 2000-02-28
SK284092B6 (sk) 2004-09-08
BG102526A (en) 1999-02-26
NO982294D0 (no) 1998-05-20
US6166083A (en) 2000-12-26
NO317287B1 (no) 2004-10-04
DE69630460D1 (de) 2003-11-27
DK0862424T3 (da) 2003-12-29
CA2238271C (en) 2008-08-12
HUP0000180A3 (en) 2001-10-29
HU225235B1 (en) 2006-08-28
CZ289643B6 (cs) 2002-03-13
CZ156598A3 (cs) 1998-08-12

Similar Documents

Publication Publication Date Title
BG64166B1 (bg) Твърди дозирани форми, съдържащи флурбипрофен
Collins et al. Bioadhesive lozenge for the improved delivery of cetylpyridinium chloride
RU2203046C2 (ru) Способ изготовления таблеток флурбипрофена
MXPA02003312A (es) Composiciones que tienen estabilidad mejorada.
WO1998052545A1 (en) Pharmaceutical compositions of flurbiprofen and burn-masking agent for treating sore throat
WO1998052540A1 (en) Pharmaceutical compositions
AU685741B2 (en) Sprayable analgesic composition and method of use
RU2311176C2 (ru) Амброксол для лечения болей в полости рта и глотки
US5286490A (en) Transdermal fluoride medication
JP2000063268A (ja) 口腔粘膜付着型徐放性錠剤及び歯周疾患治療剤
JP6315741B2 (ja) ＮＳＡＩＤｓまたはヘパリン類含有口腔用組成物
KR20150048890A (ko) 플루르비프로펜을 포함하는 약학적 조성물
ES2344984T3 (es) Composicion farmaceutica basada en ketorolaco o una de sus sales farmaceuticamente aceptables y uso del ketorolaco o sus sales en composiciones farmaceuticas.
US5874065A (en) Oral anti-acid paste and methods of use
JP2015178462A (ja) イブプロフェンの口腔内濯ぎ剤
Russell et al. Oropharynx